CRITICAL REVIEW ON KAMPAVATA – KAMPAVATA NIDAN PANCHAKA AND AYURVEDIC TREATMENT WITH SPECIAL REFERENCE TO PARKINSON’S DISEASE
DOI:
https://doi.org/10.70066/jahm.v9i3.440Abstract
Kampavata is described under Vatavyadhi in Ayurvedic classics. The word Kampavata it comes under the heading of Vataj Nanatmaj Vyadhi. On the basis of signs and symptoms of Kampavata it can be correlated with Parkinson’s Disease in modern era. It is a neurodegenerative disorder of the nervous system mainly affecting the motor system of the body. Parkinsonism is prevalent all over the world and has no definitive treatment in conventional medicine and another hand Ayurveda is an ocean for Vatavyadhi Chikitsa. The Ayurvedic treatment strategy is to combat Vata Dosha and to sustain neuronutrition by Shaman, Shodhan and Rasayana remedies. So it becomes necessary to understand the Kampavata it’s lakshanas etiopathogenesis properly for better management approach towards Kampavata with various classical drugs.
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Vasudha Gurav

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors retain the copyright of their work and grant the Journal of Ayurveda and Holistic Medicine (JAHM) the right of first publication. All published articles are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) license, which permits non-commercial sharing, use, distribution, and adaptation with proper attribution and the same license terms.
JAHM ensures free, irrevocable, worldwide access to its content. Users may copy, distribute, display, and share published works for non-commercial purposes with appropriate credit to the author(s) and the journal. Limited printed copies for personal, non-commercial use are allowed under the same license.
If a submission is not accepted for publication, the author(s) will be notified.
By submitting, authors confirm that the work is original, that all listed authors have contributed and approved it, and that it does not infringe any third-party rights or duplicate work submitted elsewhere.